Abstract
CRP is not only an excellent biomarker of inflammation, but it is also a direct participant in atherogenesis. It provides a valuable tool for identifying patients at risk of cardiovascular events in primary prevention in conjunction with lowering LDL cholesterol and may also have utility in the treatment of acute coronary syndromes and with percutaneous coronary intervention therapy. Finally, CRP will provide a readily accessible marker for further testing of the inflammatory hypothesis in atherosclerosis.
Original language | English (US) |
---|---|
Pages (from-to) | 370-372 |
Number of pages | 3 |
Journal | Circulation |
Volume | 107 |
Issue number | 3 |
DOIs | |
State | Published - Jan 28 2003 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)